Now let's turn to this morning's new stock coverage, a list that includes travel and financial firms in addition to Papa Murphy's. Aegerion Pharmaceuticals (NASDAQ:AEGR): Shares are tumbling 2.08% as we speak after getting assigned …
Within about a year of the time I first discovered this stock, AEGR shares shot up from $13 per share to a high of $101 per share. (Due to other market variables, including some unfortunate statements made by the company's CEO that ended …
Whether investors will digest such a huge slate of companies will be a big test of the resilience of the stock market," reports USA Today ... Aegerion Pharmaceuticals, Inc. (AEGR): Engages in the development and commercialization of …
Under the deal, Aegerion shareholders will receive 1.0256 share per share (Nasdaq:AEGR). Members of the investor syndicate ... were up after the announcement Wednesday. Based on recent stock prices, Aegerion has a market value …
41y
The stock traded in a range of $8.50 to $9.51 ... moving below its 200-day moving average or $39.01. Aegerion Pharmaceuticals (AEGR) rose 6.5% to close at $14.42, approaching its 50-day moving average of $14.73. It has also …
Mr. Lewis is a former co-founder, in 2005, of Aegerion Pharmaceuticals, Inc. (“Aegerion”; Nasdaq: AEGR), a biopharmaceutical company focused on developing therapies for rare diseases. At Aegerion, Mr. Lewis served in a …
2010 to YTD 2016 9 Aegerion Pharma Acquires Rights to Myalept from Amylin Pharma 10 Aegerion Pharma Completes …
The shares of Aegerion Pharmaceuticals surged after Sarissa Capital Management disclosed its stake in the company. The stock was trading at $25.70 per share, up by more than 8% to $25.87 per share at the time of this writing around …
Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development and commercialization of therapies for patients with debilitating rare diseases. It operates through pharmaceuticals segment. Its products include …
Reuters10mon
The year has turned out to be rather challenging as far as stock prices are concerned. Oil price volatility, a strong U.S. dollar, China growth worries, sluggishness in other emerging markets, slumping commodities, and geopolitical tensions …